The U.S. biotech sector has seen significant growth in 2024, while China's biotech index has declined. This shift is partly attributed to the proposed BIOSECURE Act, introduced in January 2024, which aims to distance the U.S. from Chinese companies in the biotech industry, according to an aticle in Bioscpace The...